Pharmacokinetics and normal scintigraphic appearance of 99mtc aprotinin

Sally M. Sojan, Douglas R. Smyth, Chris Tsopelas, David Mudge, Peter J. Collins, Barry E. Chatterton

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

To confirm the pharmacokinetics and biodistribution of 99mTc aprotinin in normal volunteers and to determine the optimum time for scanning post-injection, prior to further investigations of 99mTc aprotinin as an imaging agent for amyloidosis.

Original languageEnglish
Pages (from-to)535-539
Number of pages5
JournalNuclear Medicine Communications
Volume26
Issue number6
DOIs
Publication statusPublished or Issued - Jun 2005
Externally publishedYes

Keywords

  • Amyloidosis
  • Aprotinin
  • Technetium

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this